The Searle Company Limited has transmitted its annual financial statements for the year ended June 30, 2026, which have been audited and are now available for review.
- The company reported a revenue of PKR 34,342.63M, reflecting a growth compared to the previous year.
- Net Profit After Tax (PAT) stood at PKR 5,505.48M, indicating a positive performance.
- Earnings Per Share (EPS) for the year was PKR 1.00, with a cash dividend declared at 10% (PKR 1 per share).
- The financial statements include a significant increase in trade receivables, amounting to PKR 12,348.04M, which is primarily due to transactions with associated companies.
- The debt to capital ratio improved to 14%, down from 19% last year, suggesting better capital management.
- The company continues to focus on expanding its biotechnology and pharmaceutical product lines, with notable launches during the fiscal year.
- The annual general meeting is scheduled for October 22, 2026, where shareholders will vote on key resolutions including the appointment of auditors and director elections.